Pacemaker implantation after tricuspid valve replacement
Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement - Single Center Experience
This study is testing how to best manage pacemaker implantation in patients who have had a transcatheter tricuspid valve replacement to improve their care and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 25 (estimated) |
| Sex | All |
| Sponsor | Deutsches Herzzentrum Muenchen Academic / other |
| Locations | 1 site (München, Bavaria) |
| Trial ID | NCT06814574 on ClinicalTrials.gov |
What this trial studies
This study investigates the management of pacemaker implantation in patients who have undergone transcatheter tricuspid valve replacement (TTVR), a procedure associated with a high risk of complete atrioventricular block. The goal is to determine the optimal therapeutic approach for these patients, as the best practices for pacemaker management following TTVR are currently unclear. By observing patients post-TTVR, the study aims to gather data that could inform future guidelines and improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are patients scheduled to undergo transcatheter tricuspid valve replacement.
Not a fit: Patients who do not require transcatheter tricuspid valve replacement or those with contraindications to the procedure may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients undergoing TTVR, potentially reducing complications related to AV block.
How similar studies have performed: While there is limited information on similar studies, the approach of optimizing pacemaker management in the context of TTVR is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Transcatheter Tricuspid Valve Replacement Exclusion Criteria: * no defined exclusion criteria
Where this trial is running
München, Bavaria
- Deutsches Herzzentrum München — München, Bavaria, Germany (Recruiting)
Study contacts
- Study coordinator: Carsten Lennerz, PD Dr. med.
- Email: lennerz@dhm.mhn.de
- Phone: 0049 89 1218 4401
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.